COMMUNIQUÉS West-GlobeNewswire
-
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
18/05/2026 -
Memopezil Claims Evaluated (2026 Official Website Scam WARNING Update) Avoid Fake Complaints & Hidden Risks
18/05/2026 -
Press Release: ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATD
18/05/2026 -
Communiqué de presse : ATS : Les données de phase 2 démontrent la supériorité de l'efdoralprin alfa par rapport au traitement de substitution standard pour atteindre des taux de fAAT plus élevés dans le DAAT
18/05/2026 -
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend
18/05/2026 -
NADP: provider, patient benefits rose; dental plan enrollment fell in 2024
18/05/2026 -
Ipsen - April 2026- Monthly information relative to the total number of voting rights and shares composing the share capital
18/05/2026 -
Ipsen - Avril 2026 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
18/05/2026 -
Letter to Shareholders from CEO Dr. Ryan Saadi
18/05/2026 -
Disclosure of transparency notifications from BlackRock, Inc.
18/05/2026 -
Carbios announces a change in its governance and the appointment of Benoît Grenot as Chief Executive Officer
18/05/2026 -
Carbios annonce une évolution de sa gouvernance et la nomination de Benoît Grenot en qualité de Directeur Général.
18/05/2026 -
Capitol Hill Briefing To Spotlight Critical Health Care Services for Adults With Communication Disorders
18/05/2026 -
Upstream Bio Presents New Data from Phase 2 VIBRANT Trial of Verekitug Demonstrating Improvement in Asthma Symptom Control in Participants with CRSwNP and Comorbid Asthma at the ATS 2026 International Conference
18/05/2026 -
Philips highlights advances in imaging and physiology to support complex PCI at EuroPCR 2026
18/05/2026 -
Arvinas Employees Give Back During Company-wide Impact Day
18/05/2026 -
UPDATE - Quince Therapeutics Announces Clinically Meaningful Improvements Across Functional, Hemodynamic and Biomarker Measures in Phase 2 Study in PAH and PH-ILD
18/05/2026 -
Arbor Biotechnologies Appoints Mathew Pletcher, Ph.D., as Chief Scientific Officer
18/05/2026 -
Red Ribbon Recovery Indiana reports strong patient outcomes in first year of operation
18/05/2026
Pages